Cancers, Vol. 16, Pages 1721: Textbook Neoadjuvant Outcome & mdash;Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment

Cancers, Vol. 16, Pages 1721: Textbook Neoadjuvant Outcome—Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment Cancers doi: 10.3390/cancers16091721 Authors: Zuzanna Pelc Katarzyna Sędłak Magdalena Leśniewska Katarzyna Mielniczek Katarzyna Chawrylak Magdalena Skórzewska Tomasz Ciszewski Joanna Czechowska Agata Kiszczyńska Bas P. L. Wijnhoven Johanna W. Van Van Sandick Ines Gockel Suzanne S. Gisbertz Guillaume Piessen Clarisse Eveno Maria Bencivenga Giovanni De Manzoni Gian Luca Baiocchi Paolo Morgagni Riccardo Rosati Uberto Fumagalli Romario Andrew Davies Yutaka Endo Timothy M. Pawlik Franco Roviello Christiane Bruns Wojciech P. Polkowski Karol Rawicz-Pruszyński The incidence of gastric cancer (GC) is expected to increase to 1.77 million cases by 2040. To improve treatment outcomes, GC patients are increasingly treated with neoadjuvant chemotherapy (NAC) prior to curative-intent resection. Although NAC enhances locoregional control and comprehensive patient care, survival rates remain poor, and further investigations should establish outcomes assessment of current clinical pathways. Individually assessed parameters have served as benchmarks for treatment quality in the past decades. The Outcome4Medicine Consensus Conference underscores the inadequacy of isolated metrics, leading to increased recognition and adoption of composite measures. One ...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research